Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Lakewood-Amedex Biotherapeutics (NASDAQ:LABT – Free Report) from a strong sell rating to a sell rating in a research report released on Sunday morning,Wall Street Zen reports. Separately, Weiss Ratings initiated coverage on Lakewood-Amedex Biotherapeutics in a report on Monday, July 20th. They issued a “sell (e-)” rating for the […]
9 Sep 05:06 · The Markets Daily